Merck Sharp & Dohme Corp. v. Lupin Limited et al
| Merck Sharp & Dohme Corp. |
| Lupin Pharmaceuticals, Inc. and Lupin Limited |
| 1:2020cv00776 |
| June 9, 2020 |
| US District Court for the District of Delaware |
| Richard G Andrews |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on August 7, 2020. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| CORRECTING ENTRY: Date corrected to August 18, 2020 in the remark above regarding the dial-in information for the Markman/Status conference. Associated Cases: 1:19-md-02902-RGA et al. (lak) |
| Remark: The dial-in information for the August 18, 2020 Markman/Status Conference is as follows: 1-202-503-1666 Conference ID: 14483986#. Associated Cases: 1:19-md-02902-RGA et al. (lak) |
Filing 19
ORAL ORDER: The Markman hearing scheduled for August 18, 2020, will be held using Skype for business. A joint email with the email addresses for all those participating in the hearing shall be due to the Court's Case Manager by 4:00 PM on 8/7/2020. Ordered by Judge Richard G. Andrews on 8/3/2020. Associated Cases: 1:19-md-02902-RGA et al.(nms)
|
| Filing 18 NOTICE OF SERVICE of Notice of Deposition Pursuant to Federal Rule of Civil Procedure 30(b)(6) filed by Merck Sharp & Dohme Corp..(Silver, Daniel) |
| Filing 17 NOTICE OF SERVICE of Core Technical Documents filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Ewing, Alexandra) |
|
Filing 16
SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 8/24/2020. Amended Pleadings due by 8/24/2020. Fact Discovery completed by 11/20/2020. A Markman Hearing is set for 8/18/2020, at 9:00 AM in Courtroom 6A. A Pretrial Conference is set for 9/10/2021, at 9:00 AM in Courtroom 6A. A 3 day Bench Trial is set to start 10/4/2021, at 8:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 7/17/2020. (nms)
|
| CASE REFERRED to Chief Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at # https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf (cak) |
| Filing 15 NOTICE OF SERVICE of (1) Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) and (2) Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Cottrell, Frederick) |
| Filing 14 NOTICE OF SERVICE of (1) Plaintiffs Initial Disclosures Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure and Paragraph 3 of the Delaware Default Standard for Discovery and (2) Plaintiffs Initial Disclosures Identifying Defendants Accused Products and Plaintiffs Asserted Patents filed by Merck Sharp & Dohme Corp..(Silver, Daniel) |
| Filing 13 PROPOSED Scheduling Order, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 7/17/2020 (nms). |
| Filing 12 ANSWER to #8 Answer to Complaint, Counterclaim by Merck Sharp & Dohme Corp..(Silver, Daniel) |
| Pro Hac Vice Attorney Jonathan E. Bachand for Lupin Limited and Lupin Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Pro Hac Vice Attorney Andrea L. Cheek for Lupin Limited and Lupin Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Pro Hac Vice Attorney William R. Zimmerman for Lupin Limited and Lupin Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
|
SO ORDERED, re #10 MOTION for Pro Hac Vice Appearance of Attorney William R. Zimmerman, Jonathan E. Bachand, and Andrea Cheek, filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. Signed by Judge Richard G. Andrews on 6/25/2020. (nms)
|
| Filing 11 NOTICE of Appearance by Alexandra M. Ewing on behalf of Lupin Limited, Lupin Pharmaceuticals, Inc. (Ewing, Alexandra) |
| Filing 10 MOTION for Pro Hac Vice Appearance of Attorney William R. Zimmerman, Jonathan E. Bachand, and Andrea Cheek - filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Cottrell, Frederick) |
| Filing 9 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Nanomi B.V. for Lupin Limited; Corporate Parent Lupin Inc. for Lupin Pharmaceuticals, Inc. filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Cottrell, Frederick) |
| Filing 8 ANSWER to #1 Complaint, Defenses and COUNTERCLAIMS against Merck Sharp & Dohme Corp. by Lupin Pharmaceuticals, Inc., Lupin Limited.(Cottrell, Frederick) Modified on 6/25/2020 (nms). |
| Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Filing 7 WAIVER OF SERVICE returned executed by Merck Sharp & Dohme Corp.: For Lupin Pharmaceuticals, Inc. waiver sent on 6/11/2020, answer due 8/10/2020. (Silver, Daniel) |
| Filing 6 WAIVER OF SERVICE returned executed by Merck Sharp & Dohme Corp.: For Lupin Limited waiver sent on 6/11/2020, answer due 8/10/2020. (Silver, Daniel) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Merck & Co., Inc. for Merck Sharp & Dohme Corp. filed by Merck Sharp & Dohme Corp.. (lak) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,326,708. (lak) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 4/27/2020. Date of Expiration of Patent: 11/24/2026.Thirty Month Stay Deadline: 10/27/2022. (lak) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (lak) |
| Filing 1 COMPLAINT - filed against Lupin Limited, Lupin Pharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-2982710.) - filed by Merck Sharp & Dohme Corp. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet) (lak) |
| No Summons Issued. (lak) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
